Tenaya reports interim data from gene therapy trial for rare heart condition
Corroborated by 2 sources from 2 publishers
TL;DR
Reports differ across sources; according to seekingalpha.com, company Participants Michelle Corral - Vice President of Investor Relationship & Corporate Communications Faraz Ali - CEO, Interim Principal Financial Officer & Director Whittemore G.
Sources
1
Investing.com News
https://www.investing.com/news/company-news/tenaya-reports-interim-data-from-gene-therapy-trial-for-rare-heart-condition-93CH-4723944
2
Seeking Alpha Market News
https://seekingalpha.com/article/4911436-tenaya-therapeutics-inc-tnya-discusses-interim-data-from-mypeakminus-1-trial-of-tnminus-201?source=feed_all_articles
3
Seeking Alpha Market News
https://seekingalpha.com/article/4911434-tenaya-therapeutics-inc-tnya-discusses-interim-data-from-mypeakminus-1-trial-of-tnminus-201?source=feed_all_articles